Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BrightSpring Health Services (BTSG) EBIT (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed EBIT for 3 consecutive years, with $108.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 29.78% year-over-year to $108.1 million, compared with a TTM value of $295.3 million through Dec 2025, up 26.11%, and an annual FY2025 reading of $295.3 million, up 43.07% over the prior year.
  • EBIT was $108.1 million for Q4 2025 at BrightSpring Health Services, up from $87.8 million in the prior quarter.
  • Across five years, EBIT topped out at $154.0 million in Q4 2024 and bottomed at -$123.8 million in Q4 2023.
  • Average EBIT over 3 years is $40.4 million, with a median of $51.1 million recorded in 2023.
  • The sharpest move saw EBIT tumbled 129.74% in 2024, then soared 430.87% in 2025.
  • Year by year, EBIT stood at -$123.8 million in 2023, then soared by 224.35% to $154.0 million in 2024, then dropped by 29.78% to $108.1 million in 2025.
  • Business Quant data shows EBIT for BTSG at $108.1 million in Q4 2025, $87.8 million in Q3 2025, and $48.6 million in Q2 2025.